Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Twist Bioscience Corp shares valued at $120,000 were sold by Laponis Adam on Jan 13 ’26. At $40.00 per share, Laponis Adam sold 3,000 shares. The insider’s holdings dropped to 137,031 shares worth approximately $5.98 million following the completion of this transaction.
Also, Finn Patrick John sold 23,279 shares, netting a total of over 931,160 in proceeds. Following the sale of shares at $40.00 each, the insider now holds 312,883 shares.
Before that, Laponis Adam had sold 2,738 shares from its account. In a trade valued at $96,545, the Chief Financial Officer traded Twist Bioscience Corp shares for $35.26 each. Upon closing the transaction, the insider’s holdings decreased to 2,738 shares, worth approximately $6.11 million.
As published in their initiating research note from Stephens on November 04, 2025, Twist Bioscience Corp [TWST] has been an Overweight and the price target has been revised to $41. Analysts at Wolfe Research started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid December. As of June 04, 2024, Guggenheim has initiated its “Buy” rating for TWST. Earlier on January 17, 2024, Goldman upgraded its rating. Their new recommendation was “a Buy” for TWST stock which previously was a “a Neutral”.
Analyzing TWST Stock Performance
On last trading session, Twist Bioscience Corp [NASDAQ: TWST] rose 4.80% to $43.65. The stock’s lowest price that day was $41.295, but it reached a high of $44.1475 in the same session. During the last five days, there has been a surge of approximately 8.53%. Over the course of the year, Twist Bioscience Corp shares have dropped approximately -8.22%.
Is Twist Bioscience Corp subject to short interest?
Stocks of Twist Bioscience Corp saw a sharp rise in short interest on 2025-12-31 jumping by 1.51 million shares to 14.26 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 12.75 million shares. A jump of 10.57% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.34 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.34.
Which companies own the most shares of Twist Bioscience Corp (TWST)?
In terms of Twist Bioscience Corp share price expectations, FactSet research, analysts set an average price target of 41 in the next 12 months, down nearly -1.56% from the previous closing price of $41.65. Analysts anticipate Twist Bioscience Corp stock to reach 42 by 2026, with the lowest price target being 39. In spite of this, 7 analysts ranked Twist Bioscience Corp stock as Buy at the end of 2026. On September 27, 2023, Berenberg assigned a price target of “a Buy” to the stock and initiated coverage with a $27.
